On the etiology of contact/occupational vitiligo.

PubWeight™: 1.55‹?› | Rank: Top 4%

🔗 View Article (PMID 15140065)

Published in Pigment Cell Res on June 01, 2004


Raymond E Boissy1, Prashiela Manga

Author Affiliations

1: Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0592, USA. boissyre@ucmail.uc.edu

Articles citing this

Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol (2012) 2.02

A central role for inducible heat-shock protein 70 in autoimmune vitiligo. Exp Dermatol (2013) 1.50

Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res (2012) 1.48

4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo. J Invest Dermatol (2005) 1.20

Melanocytes as instigators and victims of oxidative stress. J Invest Dermatol (2014) 1.13

Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev (2006) 1.12

HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. J Invest Dermatol (2008) 1.11

Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo. J Invest Dermatol (2014) 0.99

Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff. Exp Dermatol (2009) 0.99

HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res (2011) 0.97

A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo. Am J Pathol (2006) 0.95

Vitiligo: a possible model of degenerative diseases. PLoS One (2013) 0.94

Chemical leucoderma: Indian scenario, prognosis, and treatment. Indian J Dermatol (2010) 0.91

Chemical leukoderma: what's new on etiopathological and clinical aspects? Indian J Dermatol (2010) 0.89

Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents. Drug Discov Today Dis Mech (2008) 0.88

Effective melanoma immunotherapy in mice by the skin-depigmenting agent monobenzone and the adjuvants imiquimod and CpG. PLoS One (2010) 0.88

The Potential of Plant Phenolics in Prevention and Therapy of Skin Disorders. Int J Mol Sci (2016) 0.82

Chemical Leukoderma Associated with Vicks VapoRub. J Clin Aesthet Dermatol (2008) 0.81

Chemical Leukoderma Improved by Low-dose Steroid Pulse Therapy. Ann Dermatol (2010) 0.81

A systems-biological study on the identification of safe and effective molecular targets for the reduction of ultraviolet B-induced skin pigmentation. Sci Rep (2015) 0.80

Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. Pigment Cell Melanoma Res (2014) 0.79

A Multicenter Collaborative Study by the Korean Society of Vitiligo about Patients' Occupations and the Provoking Factors of Vitiligo. Ann Dermatol (2014) 0.79

Inhibitory effect of phthalic Acid on tyrosinase: the mixed-type inhibition and docking simulations. Enzyme Res (2011) 0.79

The mechanism of melanocytes-specific cytotoxicity induced by phenol compounds having a prooxidant effect, relating to the appearance of leukoderma. Biomed Res Int (2015) 0.77

Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles. J Skin Cancer (2013) 0.76

Chemical leukoderma induced by dimethyl sulfate. An Bras Dermatol (2017) 0.75

Dysregulated autophagy increased melanocyte sensitivity to H2O2-induced oxidative stress in vitiligo. Sci Rep (2017) 0.75

Phenolic Compounds from the Leaves of Stewartia pseudocamellia Maxim. and their Whitening Activities. Biomol Ther (Seoul) (2015) 0.75

Recent advances in understanding vitiligo. F1000Res (2016) 0.75

Chemical-Induced Vitiligo. Dermatol Clin (2017) 0.75

Dysfunction of Autophagy: A Possible Mechanism Involved in the Pathogenesis of Vitiligo by Breaking the Redox Balance of Melanocytes. Oxid Med Cell Longev (2016) 0.75

The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone. Exp Dermatol (2017) 0.75

Articles by these authors

Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol (2012) 2.02

IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol (2013) 1.65

Pink-eyed dilution protein controls the processing of tyrosinase. Mol Biol Cell (2002) 1.29

Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation. FASEB J (2010) 1.23

Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res (2009) 1.17

Pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism. Mol Biol Cell (2002) 1.14

DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency. Exp Dermatol (2005) 1.05

Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma. Clin Cancer Res (2009) 1.01

Frontiers and controversies in the pathobiology of vitiligo: separating the wheat from the chaff. Exp Dermatol (2009) 0.99

Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism. Cancer Chemother Pharmacol (2008) 0.91

Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree. J Dermatol Sci (2012) 0.79

DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis. J Drugs Dermatol (2012) 0.77

Loss of Oca2 disrupts the unfolded protein response and increases resistance to endoplasmic reticulum stress in melanocytes. Pigment Cell Melanoma Res (2013) 0.76